Prostate cancer grading, time to go back to the future.
作者信息
Egevad Lars, Delahunt Brett, Bostwick David G, Cheng Liang, Evans Andrew J, Gianduzzo Troy, Graefen Markus, Hugosson Jonas, Kench James G, Leite Katia R M, Oxley Jon, Sauter Guido, Srigley John R, Stattin Pär, Tsuzuki Toyonori, Yaxley John, Samaratunga Hemamali
机构信息
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
出版信息
BJU Int. 2021 Feb;127(2):165-168. doi: 10.1111/bju.15298. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
Prostate cancer grading, time to go back to the future.前列腺癌分级，是时候回归未来了。
BJU Int. 2021 Feb;127(2):165-168. doi: 10.1111/bju.15298. Epub 2020 Nov 27.
2
[Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].[前列腺癌。第2部分：1966 - 2015年期间各种肿瘤分级系统回顾以及国际泌尿病理学会（ISUP）新分级的未来展望]
Pathologe. 2016 Feb;37(1):11-6. doi: 10.1007/s00292-015-0124-x.
3
[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].[国际泌尿病理学会（ISUP）2014年前列腺癌Gleason分级共识会议]
Pathologe. 2016 Feb;37(1):17-26. doi: 10.1007/s00292-015-0136-6.
4
Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy".关于“直肠内磁共振成像预测 Gleason 评分 7 前列腺癌的病理 T3 期疾病：对前列腺近距离放射治疗的影响”的评论
Brachytherapy. 2013 May-Jun;12(3):202. doi: 10.1016/j.brachy.2013.01.001. Epub 2013 Feb 12.
5
Editorial comment.编辑评论。
J Urol. 2013 Mar;189(3):866. doi: 10.1016/j.juro.2012.10.133. Epub 2012 Dec 20.
6
Brachytherapy and MRI: seeing what we are missing.近距离放射治疗与磁共振成像：发现我们所遗漏的内容。
Brachytherapy. 2013 May-Jun;12(3):203. doi: 10.1016/j.brachy.2013.01.002. Epub 2013 Feb 13.
7
Words of wisdom: re: transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.智慧之言：关于经会阴磁共振图像靶向前列腺活检与经会阴模板前列腺活检在检测临床显著前列腺癌中的比较
Eur Urol. 2013 Aug;64(2):337. doi: 10.1016/j.eururo.2013.05.009.
8
Editorial Comment to Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?关于前列腺癌主动监测标准的编辑评论：它们能否应用于日本患者？
Int J Urol. 2012 Feb;19(2):167-8. doi: 10.1111/j.1442-2042.2011.02910.x. Epub 2011 Nov 17.
9
Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.为预测潜在前列腺癌患者的Gleason评分≥7建立模型，以减少不必要的前列腺活检。
Int Urol Nephrol. 2016 Apr;48(4):535-40. doi: 10.1007/s11255-016-1218-y. Epub 2016 Jan 25.
10
Re: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.关于：采用改良技术的经会阴模板引导下饱和活检：270例需要重复前列腺活检患者的结果
J Urol. 2013 Oct;190(4):1245-6. doi: 10.1016/j.juro.2013.06.102. Epub 2013 Jul 4.
引用本文的文献
1
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.肿瘤进化指标可预测局部晚期前列腺癌 10 年以上的复发情况。
Nat Cancer. 2024 Sep;5(9):1334-1351. doi: 10.1038/s43018-024-00787-0. Epub 2024 Jul 12.
2
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study.前列腺针吸活检中 Gleason 评分 8 分前列腺腺癌的预后：一项全国基于人群的研究。
Virchows Arch. 2024 Jun;484(6):995-1003. doi: 10.1007/s00428-024-03810-y. Epub 2024 Apr 29.
3
Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomy.机器人辅助根治性前列腺切除术中4级亚组的预后差异。
BJUI Compass. 2022 Jun 2;3(5):392-399. doi: 10.1002/bco2.160. eCollection 2022 Sep.
4
Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years.低剂量率近距离放射治疗后 11.8 年的肿瘤学和泌尿系统结果。
BJU Int. 2022 Nov;130 Suppl 3(Suppl 3):40-45. doi: 10.1111/bju.15845. Epub 2022 Aug 19.
本文引用的文献
1
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会（ISUP）前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
2
The utility of artificial intelligence in the assessment of prostate pathology.人工智能在前列腺病理学评估中的应用
Histopathology. 2020 May;76(6):790-792. doi: 10.1111/his.14060.
3
PreImplantation Factor immunohistochemical expression correlates with prostate cancer aggressiveness.植入前因子免疫组化表达与前列腺癌侵袭性相关。
Int J Biol Markers. 2020 Jun;35(2):82-90. doi: 10.1177/1724600820919969. Epub 2020 May 11.
4
Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.前列腺癌分级：在诊断性活检中纳入导管内癌对整体分级组的影响。
Histopathology. 2020 Sep;77(3):503-507. doi: 10.1111/his.14132. Epub 2020 Jul 28.
5
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.前列腺导管内癌是一种侵袭性的浸润性癌，应该进行分级。
Pathology. 2020 Feb;52(2):192-196. doi: 10.1016/j.pathol.2019.11.001. Epub 2019 Dec 14.
6
Anterior gland focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric magnetic resonance imaging.前腺局灶性冷冻消融：多参数磁共振成像检测到的局限性前腺癌男性患者的前列腺癌治疗的概念验证。
BMC Urol. 2019 Dec 5;19(1):127. doi: 10.1186/s12894-019-0562-5.
7
The percentage of high-grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death.前列腺活检中高级别前列腺腺癌的比例在预测前列腺癌死亡方面明显优于分级分组。
Histopathology. 2019 Oct;75(4):589-597. doi: 10.1111/his.13888. Epub 2019 Aug 13.
8
Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis.ISUP 分级组 4 中的预后差异：系统评价和荟萃分析。
Pathol Oncol Res. 2020 Jul;26(3):1367-1375. doi: 10.1007/s12253-019-00632-1. Epub 2019 Mar 14.
9
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.使用纯化的自体恶性和非恶性前列腺上皮细胞鉴定前列腺癌发生早期的新致癌事件。
BJU Int. 2019 May;123 Suppl 5:27-35. doi: 10.1111/bju.14695.
10
Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).用于核心针穿刺活检和经尿道切除及剜除标本中前列腺癌报告的数据集：国际癌症报告合作组织（ICCR）的建议。
Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.
Zotero 插件